Furthermore, CMA is also able to degrade the regulator of calcineurin 1 (RCAN1), a protein linked to neuronal death and frequently highly expressed in the brains of patients with Alzheimer’s disease [60]. Here, RCAN1 is linked to early-onset autosomal dominant Alzheimer disease.